« Back
Home /
Recombinant ACE2 Antibody, monoclonal

Recombinant ACE2 Antibody, monoclonal

Item no.	PRS-11-028-0.1mg
Manufacturer	ProSci
Amount	0.1 mg
Category	Oncology Neuroscience Aging & Neurological Disorders Infectious Diseases Viral Infections Coronavirus (COVID-19) Antibodies Immunohistochemistry Western Blot Cardiovascular Research Heart Failure Myocardial Infarction Primary Antibodies By Organ Colorectal Cancer Testicular & Prostate Cancer Gastric Cancer Uterine, Ovarian & Cervical Cancer
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, IHC
Clone	180-D-2
Specific against	other
Host	Mouse
Isotype	IgG1
Conjugate/Tag	Unconjugated
Citations	PMID: 10969042,PMID: 11815627,PMID: 14504186,PMID: 19021774,PMID: 18424768,PMID: 19185582,PMID: 27217402
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	Angiotensin-converting enzyme 2 ,Angiotensin-converting enzyme homolog,ACEH,ACE-related carboxypeptidase,Metalloprotease MPROT15
Shipping Condition	Cool pack
Available
Manufacturer - Type	Primary Antibodies
Shipping Temperature	Blue Ice
Storage Conditions	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Molecular Weight Explanation	110kDa
Manufacturer - Research Area	Infectious Disease, COVID-19
Background	Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis . Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II.
By Type	Infectious Disease, COVID-19
Badges	Recombinant
Modifications	None
Purification	Protein G purified from mice ascites
Concentration	batch dependent
Buffer	PBS, pH7.4, containing 0.05% proclin300, 50% glycerol.
Application Note	WB:1:1000~4000 IHC:IHC:1:50~100
Manufacturer - Specificity	Human
Immunogen	Recombinant Human ACE2 protein
Clonality	Recombinant Monoclonal
Disclaimer	Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
User Note	Optimal dilutions for each application to be determined by the researcher.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 12/4/2025

Express Delivery: Save 1 days

Compare

Add to wishlist

Get an offer